Clinical trials
Recruiting Observational Acquired Immunodeficiency Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 38 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Guangzhou 8th People's Hospital | 7 |
| National Cancer Institute (NCI) | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Barcelona Institute for Global Health | 1 |
| Belgian Research on AIDS and HIV Consortium | 1 |
| Castagna Antonella | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| DatAids | 1 |
| Epividian | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 38 |
| Pneumonia | 3 |
| Cardiovascular Diseases | 2 |
| HIV Infections | 2 |
| Neoplasms | 2 |
| Sarcoma, Kaposi | 2 |
| Castleman Disease | 1 |
| Cerebrovascular Disorders | 1 |
| Chronic Disease | 1 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 1 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.